| Identification | Back Directory | [Name]
(2S)-(+)-5-(1,3,5-TRIMETHYLPYRAZOL-4-YL)-2-(DIMETHYLAMINO)TETRALIN | [CAS]
1000578-26-6 | [Synonyms]
AS 19
(2S)-(+)-5-(1,3,5-TRIMETHYLPYRAZOL-4-YL)-2-(DIMETHYLAMINO)TETRALIN
2-Naphthalenamine, 1,2,3,4-tetrahydro-N,N-dimethyl-5-(1,3,5-trimethyl-1H-pyrazol-4-yl)-, (2S)- | [Molecular Formula]
C18H25N3 | [MDL Number]
MFCD08669663 | [MOL File]
1000578-26-6.mol | [Molecular Weight]
283.41 |
| Chemical Properties | Back Directory | [Boiling point ]
413.3±45.0 °C(Predicted) | [density ]
1.09±0.1 g/cm3(Predicted) | [storage temp. ]
Desiccate at -20°C | [solubility ]
<28.34mg/ml in ethanol; <28.34mg/ml in DMSO | [form ]
oil | [pka]
9.20±0.20(Predicted) | [color ]
Yellow |
| Hazard Information | Back Directory | [Uses]
A potent 5-HT7 receptor agonist | [Biological Activity]
Reported potent 5-HT 7 receptor agonist (IC 50 = 0.83 nM). In vivo, enhances memory consolidation and reverses scopolamine- or dizocilpine-induced amnesia. | [in vivo]
AS19 (0.5-10 mg/kg; subcutaneous injection; for 24 hours; male Wistar rats) treatment improves memory consolidation in an autoshaping Pavlovian/instrumental learning task[1]. | Animal Model: | Male Wistar rats (12-week-old) with autoshaping Pavlovian/instrumental learning task[1] | | Dosage: | 0.5 mg/kg, 1 mg/kg, 5 mg/kg, 10 mg/kg | | Administration: | Subcutaneous injection; for 24 hours | | Result: | Enhanced memory formation in an autoshaping Pavlovian/instrumental learning task.
|
| [IC 50]
Human 5-HT7 Receptor: 0.83 nM (IC50); Human 5-HT7 Receptor: 0.6 nM (Ki); 5-HT1A Receptor: 89.7 nM (Ki); 5-HT1B Receptor: 490 nM (Ki); 5-HT1D Receptor: 6.6 nM (Ki); 5-HT5 Receptor: 98.5 nM (Ki) | [storage]
Desiccate at -20°C | [References]
[1]. perez-garcía gs and meneses a. effects of the potential 5-ht7 receptor agonist as 19 in an autoshaping learning task. behav brain res, 2005, 163(1):136-40.
[2]. thomas dr and hagan jj. 5-ht7 receptors. current drug targets-cns & neurological disorders, 2004, 3(1): 81-90.
[3]. ulugol a, oltulu c, gunduz o, et al. 5-ht7 receptor activation attenuates thermal hyperalgesia in streptozocin-induced diabetic mice. pharmacol biochem behav, 2012, 102(2):344-8.
[4]. le?畁-ponte m, ahern gp and o'connell pj. serotonin provides an accessory signal to enhance t-cell activation by signaling through the 5-ht7 receptor. blood, 2007, 109(8):3139-46.
[5]. hoffman ms and mitchell gs. spinal 5-ht7 receptor activation induces long-lasting phrenic motor facilitation. j physiol, 2011, 589(pt 6):1397-407. |
|
| Company Name: |
|
| Tel: |
821-50328103-801 18930552037 |
| Website: |
https://www.chemicalbook.com/ShowSupplierProductsList13285/0.htm |
| Company Name: |
BOC Sciences
|
| Tel: |
|
| Website: |
https://www.bocsci.com |
| Company Name: |
Energy Chemical
|
| Tel: |
021-58432009 400-005-6266 |
| Website: |
http://www.energy-chemical.com |
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 13348960310 |
| Website: |
https://www.weikeqi-biotech.com/ |
| Company Name: |
R&D Systems, Inc
|
| Tel: |
18003437475 18003437475 |
| Website: |
www.rndsystems.com |
|